• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Radiotherapy of rare head and neck tumors
We present here a review of the literature and available guidelines for the management by radiotherapy of rare upper aerodigestive tract tumors.PMID:37596121 | DOI:10.1016/j.canrad.2023.06.020
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: L Sauvage V Calugaru G Janoray Source Type: research

RadioTransNet, Radiotherapy Translational and Preclinical Research Network: Results from the dedicated French cancer institute (INCa) call for projects
CONCLUSION: RadioTransNet project has been launched in 2018, supported by INCa, in order to structure and promote preclinical research in oncology radiotherapy and to favor collaboration between the actors of this research. INCa relied on RadioTransNet initiatives and activities, resulting in the opening of dedicated call for projects. Beyond its first main goals, RadioTransNet network is able to help to fund the human and technical resources necessary to conduct optimal translational and preclinical research in radiation oncology.PMID:37482463 | DOI:10.1016/j.canrad.2023.06.019
Source: Cancer Radiotherapie - July 23, 2023 Category: Cancer & Oncology Authors: É Bayart R De Crevoisier A Laprie F Milliat Y Prezado V Marchesi P Maingon Source Type: research

Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial
CONCLUSIONS AND RELEVANCE: This randomized clinical trial did not demonstrate a benefit of ART in decreasing xerostomia compared with standard IMRT. No significant differences were found in secondary end points except for parotid gland excretory function, as assessed by scintigraphy, or in survival rates.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01874587.PMID:37261806 | DOI:10.1001/jamaoncol.2023.1352
Source: Cancer Control - June 1, 2023 Category: Cancer & Oncology Authors: Jo ël Castelli Juliette Thariat Karen Benezery Ali Hasbini Bernard Gery Antoine Berger Xavier Liem S ébastien Guihard Sophie Chapet S ébastien Thureau Pierre Auberdiac Pascal Pommier Amandine Ruffier Lionel Perrier Anne Devillers Boris Campillo-Gimenez Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 1
This article (part 1) discusses the diagnostic and therapeutic specificities of these rare cancers, and develops the recommendations of the French ENT Cancer Expertise Network (REFCOR) concerning rare epithelial tumors, i.e., salivary tumors, sinonasal tumors, variants of conventional squamous cell carcinomas, neuroendocrine carcinomas, malignant odontogenic tumors, and ear tumors. A second article (part 2) is focused on non-epithelial tumors (sarcomas, mucosal melanomas, lymphomas, tumors of uncertain or undetermined malignancy) and describes the organization and missions of the REFCOR.PMID:37169603 | DOI:10.1016/j.bulcan.2023.04.008
Source: Cancer Control - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 2
Bull Cancer. 2023 May 9:S0007-4551(23)00202-3. doi: 10.1016/j.bulcan.2023.04.007. Online ahead of print.ABSTRACTAmong the 16,000 new cases of malignant tumors of the head and neck diagnosed in France each year, 10% are not conventional squamous cell carcinomas. These so-called rare cancers are distinguished by their presentation and patterns of failure, which is important to recognize in order to offer specific adapted management and maximize the chances of tumor control. These cancers can be rare by their histology as well as their anatomical location when arising from the paranasal sinuses, salivary glands and ear. The m...
Source: Cancer Control - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 1
This article (part 1) discusses the diagnostic and therapeutic specificities of these rare cancers, and develops the recommendations of the French ENT Cancer Expertise Network (REFCOR) concerning rare epithelial tumors, i.e., salivary tumors, sinonasal tumors, variants of conventional squamous cell carcinomas, neuroendocrine carcinomas, malignant odontogenic tumors, and ear tumors. A second article (part 2) is focused on non-epithelial tumors (sarcomas, mucosal melanomas, lymphomas, tumors of uncertain or undetermined malignancy) and describes the organization and missions of the REFCOR.PMID:37169603 | DOI:10.1016/j.bulcan.2023.04.008
Source: Bulletin du Cancer - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 2
Bull Cancer. 2023 May 9:S0007-4551(23)00202-3. doi: 10.1016/j.bulcan.2023.04.007. Online ahead of print.ABSTRACTAmong the 16,000 new cases of malignant tumors of the head and neck diagnosed in France each year, 10% are not conventional squamous cell carcinomas. These so-called rare cancers are distinguished by their presentation and patterns of failure, which is important to recognize in order to offer specific adapted management and maximize the chances of tumor control. These cancers can be rare by their histology as well as their anatomical location when arising from the paranasal sinuses, salivary glands and ear. The m...
Source: Bulletin du Cancer - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 1
This article (part 1) discusses the diagnostic and therapeutic specificities of these rare cancers, and develops the recommendations of the French ENT Cancer Expertise Network (REFCOR) concerning rare epithelial tumors, i.e., salivary tumors, sinonasal tumors, variants of conventional squamous cell carcinomas, neuroendocrine carcinomas, malignant odontogenic tumors, and ear tumors. A second article (part 2) is focused on non-epithelial tumors (sarcomas, mucosal melanomas, lymphomas, tumors of uncertain or undetermined malignancy) and describes the organization and missions of the REFCOR.PMID:37169603 | DOI:10.1016/j.bulcan.2023.04.008
Source: Cancer Control - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Rare cancers of the head and neck on behalf of the REFCOR, part 2
Bull Cancer. 2023 May 9:S0007-4551(23)00202-3. doi: 10.1016/j.bulcan.2023.04.007. Online ahead of print.ABSTRACTAmong the 16,000 new cases of malignant tumors of the head and neck diagnosed in France each year, 10% are not conventional squamous cell carcinomas. These so-called rare cancers are distinguished by their presentation and patterns of failure, which is important to recognize in order to offer specific adapted management and maximize the chances of tumor control. These cancers can be rare by their histology as well as their anatomical location when arising from the paranasal sinuses, salivary glands and ear. The m...
Source: Cancer Control - May 11, 2023 Category: Cancer & Oncology Authors: Emilien Chabrillac Caroline Even Val érie Costes-Martineau Nicolas Fakhry Laurence Digue Antoine Moya-Plana Bertrand Baujat Christian-Adrien Righini Ludovic De Gabory Benjamin Verillaud S ébastien Vergez Juliette Thariat les membres du REFCOR Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11